Leaflet FID-NA-131-I-T 37-5500 MBq capsules for therapeutic use

Product code:
W66052010
Quantity:
1
Indicated for:
thyroid disorders; radioiodine therapy
Route of administration:
oral
Substance:
sodium iodide (131I) (thyroid hormone)
ATC
V10XA01 — Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds

Precautions:

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Sodium iodide (131I) is a radioactive compound used in the treatment and diagnosis of thyroid conditions such as hyperthyroidism and thyroid cancer. It emits radiation that destroys overactive or cancerous thyroid cells.

It is administered orally, in capsule or solution form, and is quickly absorbed by the thyroid gland. Treatment with Sodium iodide (131I) is effective and minimally invasive, serving as an alternative to surgical interventions.

Side effects may include dry mouth, fatigue, or inflammation of the salivary glands. As a radioactive compound, its use requires special precautions to minimize radiation exposure.

Consult your doctor to discuss the benefits and risks of treatment with Sodium iodide (131I). It is important to follow all instructions to ensure the safety and effectiveness of the treatment.

General data about FID-NA-131-I-T 37-5500 MBq

Substance:
sodium iodide (131I)
Date of latest medicines list:
01-06-2026
Product code:
W66052010
Concentration:
37-5500MBq
Pharmaceutical form:
capsules for therapeutic use
Quantity:
1
Product type:
Generic medicine
Price:
2213.96 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
NATIONAL CENTRE FOR NUCLEAR RESEARCH - POLONIA
Holder:
S.C. FIDELIO FARM SRL - ROMANIA
Number:
11768/2019/01
Shelf life:
21 days

Concentrations available for sodium iodide (131I)

  • 0.333 MBq - 3.7 MBq
  • 0.37-3.7GBq
  • 0.37-36MBq
  • 14.8-3700MBq
  • 3.7MBq
  • 3.7MBq.1.85MBq.0.925MBq
  • 37-5500MBq
  • 37-7400MBq
  • 37MBq-5.55GBq
  • 38-7400MBq
  • 50- 7400MBq

Compensation lists for FID-NA-131-I-T 37-5500 MBq Fidelio

NHP 7 (C2) - Endocrine diseases

Price
2213.96 RON
Copayment
1668.42 RON
Patient
545.54 RON